Europe — EMA
Paliperidone Teva Pharma (Paliperidone Palmitate)
Paliperidone palmitate, the active ingredient in Paliperidone Teva Pharma, is an atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use.
Request sourcing
What is Paliperidone Palmitate?
Paliperidone palmitate, the active ingredient in Paliperidone Teva Pharma, is an atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It treats schizophrenia and schizoaffective disorder in adults and adolescents. GNH USA supplies Paliperidone Teva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Paliperidone Teva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Paliperidone Palmitate used for?
Paliperidone palmitate is an atypical antipsychotic used in the management of chronic psychotic disorders that act on dopamine and serotonin pathways.
- Schizophrenia: Reduces relapse risk and stabilises symptoms in adult patients. - Schizoaffective disorder: Improves mood and psychotic symptom control in adults. - Maintenance therapy: Provides once‑monthly or once‑quarterly dosing to maintain symptom control after acute stabilization. - Pediatric use: Approved for adolescents aged 12‑17 with schizophrenia, supporting long‑term stability. - Early‑stage treatment of schizophrenia in young adults ( 5 to 12 months after initial episode on oral pal…
What are the side effects of Paliperidone Palmitate?
It … … …
What precautions apply to Paliperidone Palmitate?
…
What does Paliperidone Palmitate interact with?
…
